An eTMF decision made in 2026 has to account for expectations that didn't carry the same weight a few years ago — risk-proportionate essential records under ICH E6(R3) Appendix C, decentralized trial elements under Annex 2, and AI-assisted classification that's now common enough to be a real evaluation factor rather than a novelty. A selection framework built around 2020-era priorities misses a lot of what actually matters now. Here's a seven-step approach sponsors can use to evaluate an eTMF system with current expectations in mind.
Before comparing platforms, define how your organization intends to apply the risk-proportionate approach to essential records that ICH E6(R3) Appendix C describes. A platform evaluation should test whether the system can support study-specific record scoping, not just whether it ships with a standard DIA TMF Reference Model template.
A completeness score alone doesn't tell you whether a TMF is genuinely inspection-ready. Ask vendors to demonstrate document-level QC status, classification confidence scoring, and how quickly a specific document can be located and retrieved — not just an aggregate completeness number.
Don't take audit trail claims at face value. Ask to see, in a demo, how the system would answer a specific question: who approved a particular document, when, and what changed in that document's history. The speed and clarity of that answer tells you more than a feature list.
AI-based document classification is now a standard capability across many eTMF platforms, but the quality varies significantly. Ask specifically about classification confidence scoring, how low-confidence documents are routed for human review, and what happens when the system gets a classification wrong the answer to that last question matters more than the headline accuracy claim.
With Annex 2 extending GCP considerations to decentralized, pragmatic, and real-world-data trial elements, ask how the platform handles essential records generated by remote visits, digital consent, and non-traditional data sources. This is a newer evaluation criterion that many legacy platforms haven't fully addressed yet.
An eTMF that operates in isolation from your other eClinical systems creates the exact kind of reconciliation burden that risk-proportionate, inspection-ready documentation is supposed to reduce. Evaluate whether milestone data, safety events, and operational status are positioned to inform TMF completeness, or whether that connection has to be built and maintained manually.
Ask for a specific, demonstrable time-to-first-study-live figure, not a general claim about ease of use. Ask about support responsiveness during the critical first months of implementation, when configuration questions and edge cases cluster most heavily. These operational details often matter more to actual user experience than any single feature on a comparison sheet.
| Evaluation Area | What to Ask | Why It Matters Now |
|---|---|---|
| Record strategy | Can the system scope records by study risk and design? | Reflects ICH E6(R3) Appendix C proportionality |
| Inspection readiness | Document-level QC and retrieval speed, not just completeness % | Completeness alone doesn't prove readiness |
| Audit trail | Can it answer a specific "who approved what, when" question live? | Tests real defensibility, not just a feature claim |
| AI classification | How are low-confidence documents handled? | Accuracy claims alone don't show real-world reliability |
| Decentralized elements | Does it support records from remote/digital trial elements? | Reflects Annex 2's expanded GCP scope |
| System connection | Is it connected to CTMS, EDC, and Safety, or isolated? | Determines real reconciliation burden |
| Implementation | Specific time-to-live figure and early support model | Determines actual rollout experience, not just feature fit |
An eTMF selected without accounting for Appendix C's proportionality expectations or Annex 2's expanded scope risks becoming misaligned with current GCP guidance shortly after implementation an expensive position to be in given how disruptive a TMF platform change is once a portfolio of studies is already running on it. Building these considerations into the selection process from the start avoids having to retrofit them later.
Cloudbyz's eTMF Agent is built to support study-specific configuration rather than a single universal template, aligning with a risk-proportionate approach to essential records. Document classification includes confidence scoring with low-confidence items routed for human review, and completeness and QC status are visible at the document level, not just as an aggregate percentage.
Because Cloudbyz's eTMF shares its platform with CTMS, EDC, and Safety, TMF completeness is positioned to reflect operational and safety data directly, rather than requiring a separate manual reconciliation process.
Choosing an eTMF in 2026 means evaluating against where GCP guidance and trial design are actually heading, not just where they've been. A structured, seven-step approach makes that evaluation far more defensible than a feature checklist alone.
Book a demo with Cloudbyz.